13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 64 holding rows worth $358,275,000.
- Accession
- 0001387131-22-011394
- Filer
- CIK 1773195
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 64 entries on the cover page, a total value of $358,275,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $358,275,000 with VALUE read as thousands by filing date, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 250,000 | $89,295,000 | thousands by filing date | put |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 326,668 | $17,839,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 813,998 | $16,003,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 190,000 | $12,939,000 | thousands by filing date | |
| iShares Russell 2000 ETF | 464287655 | SHS | 70,000 | $11,544,000 | thousands by filing date | put |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 300,000 | $11,406,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 11,000,000 | $11,131,000 | thousands by filing date | principal |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 100,000 | $10,326,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 250,000 | $9,505,000 | thousands by filing date | put |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 675,753 | $9,231,000 | thousands by filing date | |
| LANTHEUS HLDGS INC | 516544103 | COM | 130,000 | $9,143,000 | thousands by filing date | |
| INARI MED INC | 45332Y109 | COM | 120,000 | $8,717,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009RAD1 | BOND | 10,000,000 | $8,544,000 | thousands by filing date | principal |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 150,000 | $8,226,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 100,000 | $6,499,000 | thousands by filing date | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 170,000 | $5,935,000 | thousands by filing date | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 746,576 | $5,771,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 100,000 | $5,484,000 | thousands by filing date | put |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 473,597 | $5,001,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 175,000 | $4,993,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 75,000 | $4,874,000 | thousands by filing date | put |
| PENUMBRA INC COM | 70975L107 | Stock | 25,000 | $4,740,000 | thousands by filing date | call |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,290,511 | $4,517,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 7,500,000 | $4,491,000 | thousands by filing date | principal |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 10,000,000 | $4,437,000 | thousands by filing date | principal |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 267,794 | $4,274,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 146,491 | $4,146,000 | thousands by filing date | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 210,138 | $3,944,000 | thousands by filing date | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 170,000 | $3,682,000 | thousands by filing date | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 400,043 | $3,616,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 350,000 | $3,577,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISITN CORP | G31658100 | CLASS A ORD SHS | 352,500 | $3,465,000 | thousands by filing date | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 110,000 | $3,237,000 | thousands by filing date | put |
| CYTOKINETICS INC | 23282W605 | COM NEW | 65,000 | $3,149,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 154,087 | $2,299,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 80,000 | $2,249,000 | thousands by filing date | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 75,000 | $2,207,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 136,434 | $2,147,000 | thousands by filing date | |
| LANTHEUS HLDGS INC | 516544103 | COM | 30,000 | $2,110,000 | thousands by filing date | put |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 1,492,771 | $2,060,000 | thousands by filing date | |
| INVESCO CURRENCYSHARES EURO | 46138K103 | EURO SHS | 20,000 | $1,809,000 | thousands by filing date | put |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 165,100 | $1,687,000 | thousands by filing date | put |
| GERON CORP | 374163103 | COM | 650,000 | $1,521,000 | thousands by filing date | put |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 25,000 | $1,475,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 626,000 | $1,465,000 | thousands by filing date | call |
| PRECIGEN INC | 46122TAA0 | NOTE 3.500% 7/0 | 1,500,000 | $1,455,000 | thousands by filing date | principal |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 96,318 | $1,398,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 137,200 | $1,261,000 | thousands by filing date | call |
| LIANBIO ADR | 53000N108 | COM | 550,000 | $1,095,000 | thousands by filing date | |
| INVESCO CURRENCYSHARES BRITISH | 46138m109 | INDX FD | 10,000 | $1,073,000 | thousands by filing date | put |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 883,654 | $981,000 | thousands by filing date | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 242,517 | $975,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 110,000 | $792,000 | thousands by filing date | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 372,476 | $790,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 20,000 | $687,000 | thousands by filing date | call |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 250,000 | $680,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 30,000 | $538,000 | thousands by filing date | call |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 37,100 | $507,000 | thousands by filing date | put |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 187,204 | $507,000 | thousands by filing date | |
| RENOVACOR INC | 75989E106 | COM | 199,490 | $503,000 | thousands by filing date | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 81,982 | $297,000 | thousands by filing date | |
| VICKERS VANTAGE CORP I | G9440B115 | *W EXP 09/15/202 | 100,000 | $17,000 | thousands by filing date | |
| Renovacor Inc | 75989E114 | Warrant | 75,000 | $6,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 33,333 | $3,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-22-011394 | this filing | 2022-11-14 | acceptance time not in the bulk data set |